D.E. Shaw & Co

D.E. Shaw & Co’s Crescent Biopharma CBIO Stock Holding History

D.E. Shaw & Co’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-366	Closed	-$20K	–	4965
2022 Q3	$20K	Sell	366 -2,054	-85%	-$148K	﹤0.01%	4805
2022 Q2	$144K	Sell	2,420 -137	-5%	-$10.1K	﹤0.01%	4657
2022 Q1	$291K	Sell	2,557 -122	-5%	-$14.3K	﹤0.01%	4663
2021 Q4	$385K	Sell	2,679 -489	-15%	-$88.7K	﹤0.01%	4546
2021 Q3	$694K	Buy	3,168 +513	+19%	+$109K	﹤0.01%	3873
2021 Q2	$616K	Sell	2,655 -2,504	-49%	-$637K	﹤0.01%	3922
2021 Q1	$1.55M	Sell	5,159 -617	-11%	-$221K	﹤0.01%	2794
2020 Q4	$2.17M	Buy	5,776 +1,719	+42%	+$602K	﹤0.01%	2504
2020 Q3	$1.25M	Buy	4,057 +64	+2%	+$24.5K	﹤0.01%	2717
2020 Q2	$1.5M	Buy	3,993 +2,060	+107%	+$583K	﹤0.01%	2629
2020 Q1	$440K	Buy	1,933 +1,151	+147%	+$440K	﹤0.01%	3272
2019 Q4	$414K	Buy	782 +290	+59%	+$157K	﹤0.01%	3490
2019 Q3	$212K	Buy	+492	New	+$316K	﹤0.01%	3605
2018 Q2	–	Sell	-109	Closed	-$177K	–	3771
2018 Q1	$177K	Sell	109 -1,416	-93%	-$2.94M	﹤0.01%	3349
2017 Q4	$2.56M	Buy	+1,525	New	+$2.02M	﹤0.01%	1955

Other funds holding CBIO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Manhattan

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return